Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 14.7 USD 0.75% Market Closed
Market Cap: 2B USD

Relative Value

The Relative Value of one PRGO stock under the Base Case scenario is hidden USD. Compared to the current market price of 14.7 USD, Perrigo Company PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRGO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
73
Median 3Y
0.9
Median 5Y
1
Industry
2.6
Forward
0.5
vs History
vs Industry
Median 3Y
-37
Median 5Y
-37
Industry
21.4
Forward
5.2
vs History
95
vs Industry
37
Median 3Y
11.1
Median 5Y
12
Industry
16.4
vs History
vs Industry
25
Median 3Y
6.3
Median 5Y
6.3
Industry
22.8
vs History
95
vs Industry
64
Median 3Y
0.9
Median 5Y
0.9
Industry
2.2
vs History
95
vs Industry
59
Median 3Y
1.6
Median 5Y
1.6
Industry
2.9
Forward
1.2
vs History
95
vs Industry
45
Median 3Y
4.4
Median 5Y
4.5
Industry
5.5
vs History
84
vs Industry
32
Median 3Y
11.6
Median 5Y
11.7
Industry
13
Forward
7
vs History
80
vs Industry
20
Median 3Y
28.4
Median 5Y
28.4
Industry
16.5
Forward
8.1
vs History
88
vs Industry
24
Median 3Y
19.6
Median 5Y
20.1
Industry
15.6
vs History
73
vs Industry
18
Median 3Y
27
Median 5Y
26.6
Industry
18.7
vs History
95
vs Industry
65
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

PRGO Competitors Multiples
Perrigo Company PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Perrigo Company PLC
NYSE:PRGO
2B USD 0.5 -39 7.2 13.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.3 55.7 37.4 40.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
495.1B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
270.6B CHF 4.4 28.7 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
219.5B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
276.1B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
217.9B CHF 4.9 18.9 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.3 16.1 11.2 13
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.8B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
IE
Perrigo Company PLC
NYSE:PRGO
Average P/E: 25
Negative Multiple: -39
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
18.9
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.1
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average EV/EBITDA: 400.7
7.2
6%
1.2
US
Eli Lilly and Co
NYSE:LLY
37.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average EV/EBIT: 1 713.6
13.2
26%
0.5
US
Eli Lilly and Co
NYSE:LLY
40.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5